News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
651,959 Results
Type
Article (53802)
Company Profile (191)
Press Release (597966)
Section
Business (184335)
Career Advice (2534)
Deals (33416)
Drug Delivery (109)
Drug Development (78584)
Employer Resources (156)
FDA (17200)
Job Trends (14482)
News (323732)
Policy (34406)
Tag
Academia (2702)
Alliances (46466)
Alzheimer's disease (1314)
Approvals (17109)
Artificial intelligence (145)
Bankruptcy (332)
Best Places to Work (10937)
Biotechnology (123)
Breast cancer (126)
Cancer (1135)
Cardiovascular disease (108)
Career advice (2115)
Cell therapy (253)
Clinical research (62416)
Collaboration (399)
Compensation (199)
COVID-19 (2696)
C-suite (97)
Data (1114)
Diabetes (162)
Diagnostics (5943)
Drug pricing (97)
Earnings (69889)
Employer resources (143)
Events (95684)
Executive appointments (313)
FDA (17754)
Funding (338)
Gene therapy (194)
GLP-1 (668)
Government (4465)
Healthcare (18617)
Infectious disease (2787)
Inflammatory bowel disease (109)
Interviews (456)
IPO (15553)
Job creations (3901)
Job search strategy (1781)
Layoffs (470)
Legal (8163)
Lung cancer (188)
Manufacturing (189)
Medical device (13969)
Medtech (13972)
Mergers & acquisitions (17941)
Metabolic disorders (458)
Neuroscience (1608)
NextGen Class of 2024 (6323)
Non-profit (4250)
Northern California (1437)
Obesity (267)
Opinion (210)
Patents (108)
People (54556)
Phase I (18889)
Phase II (27212)
Phase III (21222)
Pipeline (464)
Postmarket research (2803)
Preclinical (7774)
Radiopharmaceuticals (236)
Rare diseases (234)
Real estate (5692)
Regulatory (23182)
Research institute (2437)
Resumes & cover letters (421)
Southern California (1256)
Startups (3500)
United States (13007)
Vaccines (636)
Weight loss (216)
Date
Today (113)
Last 7 days (745)
Last 30 days (3788)
Last 365 days (35289)
2024 (32385)
2023 (39352)
2022 (50537)
2021 (54828)
2020 (53098)
2019 (45212)
2018 (34292)
2017 (32662)
2016 (31651)
2015 (35718)
2014 (28727)
2013 (23984)
2012 (25984)
2011 (26532)
2010 (25011)
Location
Africa (812)
Arizona (173)
Asia (39699)
Australia (6585)
California (3189)
Canada (1169)
China (249)
Colorado (140)
Connecticut (160)
Europe (90330)
Florida (451)
Georgia (118)
Illinois (352)
Indiana (182)
Kansas (91)
Maryland (574)
Massachusetts (2500)
Michigan (141)
Minnesota (250)
New Jersey (943)
New York (913)
North Carolina (720)
Northern California (1437)
Ohio (131)
Pennsylvania (803)
South America (1206)
Southern California (1256)
Texas (445)
Washington State (343)
651,959 Results for "medical microinstruments s r l".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
News
Tenon Medical(R) Announces Issuance of Three U.S. Patents
October 18, 2024
·
4 min read
Deals
Frontage Laboratories Acquires Accelera S.r.l.'s Bioanalytical and DMPK Businesses
Frontage Laboratories, Inc. today announced that, through its wholly-owned subsidiary Frontage Europe S.r.l., it has completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera).
January 2, 2024
·
5 min read
Business
Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer
Daxor Corporation today announces the appointment of Dr. John L. Jefferies, M.D., M.B.A., M.P.H., F.A.C.C., F.A.H.A., F.A.A.P., F.H.F.S.A., F.E.S.C., F.R.C.P.E., as Chief Medical Officer.
June 5, 2024
·
4 min read
MMI Completes First Symani® Clinical Cases in the U.S. Following FDA Commercial Authorization
MMI (Medical Microinstruments, Inc.) today announced the completion of its first clinical cases in the United States using the Symani® Surgical System.
May 1, 2024
·
3 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Press Releases
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
October 28, 2024
·
3 min read
MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.
MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that its Symani® Surgical System is now commercially available in the United States.
April 8, 2024
·
4 min read
FDA
EPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY® (epcoritamab-bysp) for the treatment of adults with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of systemic therapy.
June 26, 2024
·
17 min read
Business
City of Hope Appoints Angelique Richard, Ph.D., R.N., as Chief Operating Officer
City of Hope®, one of the largest cancer research and treatment organizations in the United States, announced that effective June 10, Angelique L. Richard, Ph.D., R.N., will be chief operating officer of City of Hope National Medical Center, City of Hope Los Angeles, City of Hope Orange County and City of Hope’s Southern California clinical network.
June 3, 2024
·
4 min read
Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
Medical Microinstruments, Inc. (MMI) , a robotics company dedicated to improving clinical outcomes for patients undergoing microsurgery, today announced it has raised $75 million in Series B financing.
July 20, 2022
·
4 min read
1 of 65,196
Next